tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
BioInvent International AB (BOVNF)
OTHER OTC:BOVNF
US Market
BOVNF
BioInvent International AB
RESEARCH TOOLSreports

BioInvent International AB (BOVNF) Stock News & Sentiment

Compare
4 Followers
BioInvent’s BT-001 Clinical Trial Termination: Implications for Investors
Premium
Company Announcements
BioInvent’s BT-001 Clinical Trial Termination: Implications for Investors
2d ago
BOVNF
BioInvent Reports Promising Phase 2a Trial Results for NHL Treatment
Premium
Company Announcements
BioInvent Reports Promising Phase 2a Trial Results for NHL Treatment
8d ago
BioInvent’s BI-1808 Shows Promise in Early Phase 2a CTCL Trial
Premium
Company Announcements
BioInvent’s BI-1808 Shows Promise in Early Phase 2a CTCL Trial
9d ago
BioInvent Publishes Promising Early Data for BI-1607 in Cancer Treatment
Premium
Company Announcements
BioInvent Publishes Promising Early Data for BI-1607 in Cancer Treatment
28d ago
BioInvent’s BI-1808 Receives Positive EMA Opinion for Orphan Drug Designation
Premium
Company Announcements
BioInvent’s BI-1808 Receives Positive EMA Opinion for Orphan Drug Designation
29d ago
BioInvent’s BI-1910 Shows Promise in Phase 1 Trials for Solid Tumors
Premium
Company Announcements
BioInvent’s BI-1910 Shows Promise in Phase 1 Trials for Solid Tumors
1M ago
BioInvent to Present Promising Phase 2a Data at ASH 2025
Premium
Company Announcements
BioInvent to Present Promising Phase 2a Data at ASH 2025
1M ago
More BOVNF News >

BOVNF News on the Web

BioInvent’s BI-1808 Shows Promise in Early Phase 2a CTCL Trial
TipRanks News
Neutral
BioInvent Announces Board of Directors Update
TipRanks News
Neutral
Stifel Nicolaus Remains a Buy on BioInvent International AB (BOVNF)
TipRanks News
Neutral
BioInvent Reports Strong Q2 2025 Earnings and Clinical Progress
TipRanks News
Neutral
Invitation to Presentation of BioInvent's Year-end Report 2024
Yahoo Finance
Neutral
Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag
Benzinga
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average0 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BOVNF’s Media Buzz Sentiment?
Currently, no data Available
What is BOVNF’s weekly average amount of articles?
Currently, no data Available
What is BOVNF’s News Sentiment?
Currently, no data Available
Healthcare Stocks that are Trending in the News
WSTWest Pharmaceutical Services
TLRYTilray
CRBPCorbus Pharmaceuticals
BEATHeartBeam
HIKHikma Pharmaceuticals
Showing the stocks with the most bullish news sentiment over the past week